Xencor, Inc. (XNCR)
NASDAQ: XNCR · Real-Time Price · USD
24.00
+0.61 (2.61%)
Oct 15, 2026, 4:00 PM EDT - Market closed
Xencor Market Cap
Xencor has a market cap or net worth of $1.78 billion as of October 15, 2026. It is the 7,159th most valuable company in the world and the 1,846th biggest in the United States. Its market cap has increased by 101.30% in one year.
Market Cap
1.78B
Enterprise Value
1.39B
1-Year Change
101.30%
Global Rank
Country Rank
#1,846 United States
Category
ChartMarket Cap Chart
Since December 3, 2013, Xencor's market cap has increased from $245.40M to $1.78B, an increase of 627.17%. That is a compound annual growth rate of 16.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 1.78B | 63.22% |
| Dec 31, 2025 | 1.09B | -32.02% |
| Dec 31, 2024 | 1.61B | 24.44% |
| Dec 29, 2023 | 1.29B | -17.18% |
| Dec 30, 2022 | 1.56B | -33.50% |
| Dec 31, 2021 | 2.35B | -6.40% |
| Dec 31, 2020 | 2.51B | 28.51% |
| Dec 31, 2019 | 1.95B | -4.07% |
| Dec 31, 2018 | 2.03B | 97.53% |
| Dec 29, 2017 | 1.03B | -4.93% |
| Dec 30, 2016 | 1.08B | 82.97% |
| Dec 31, 2015 | 591.80M | 17.51% |
| Dec 31, 2014 | 503.60M | 87.28% |
| Dec 31, 2013 | 268.90M | 9.58% |
| Dec 3, 2013 | 245.40M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Mesoblast | 1.84B |
| Agios Pharmaceuticals | 1.80B |
| Vir Biotechnology | 1.80B |
| Zymeworks | 1.78B |
| Trevi Therapeutics | 1.75B |
| Sarepta Therapeutics | 1.74B |
| Biohaven | 1.72B |
| Septerna | 1.70B |